Bicara Therapeutics BCAX PP&E (Net)
PP&E (Net) at other companies
Other financials
Where this comes from
Reported directly by Bicara Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.
The official record: Bicara Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bicara Therapeutics's pp&e (net).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bicara Therapeutics's PP&E (net)?
- Bicara Therapeutics (BCAX) reported PP&E (net) of $346K in Q1 2026.
- How has Bicara Therapeutics's PP&E (net) changed year-over-year?
- Bicara Therapeutics's PP&E (net) increased by 154.4% year-over-year, from $136K to $346K.
- What is the long-term trend for Bicara Therapeutics's PP&E (net)?
- Over 2 years (2023 to 2025), Bicara Therapeutics's PP&E (net) has grown at a 27.8% compound annual growth rate (CAGR), from $202K to $330K.
- What does PP&E (net) mean?
- Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.